The mds Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mds Hub cannot guarantee the accuracy of translated content. The mds and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mds content recommended for you
Theo de Witte
Chair
Professor Theo de Witte, chair of the MDS Hub, ran the Hematology Department at Radboud University Medical Center, Nijmegen, NL, from 1990 to 2009, following which he continued his clinical and scientific research in the Departments of Tumor Immunology and Hematology.
Professor de Witte has been, and still is, active on many national and international scientific boards, for example, he is a board member of the international MDS Foundation and a member of the steering committee for the European LeukemiaNet (ELN). He was also the chief investigator and project leader of the EUMDS Registry and coordinator of the MDS-RIGHT project. Currently, he is a senior consultant of the EUMDS-Registry and the ELN MDS Workpackage .
Professor de Witte's main scientific interests are the biology and treatment of myelodysplastic syndromes/acute myeloid leukemia and cellular immunotherapy of hematologic malignancies.
Filter by content: